Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.

Abstract

A retrospective study was done in 86 patients on dialysis in order to evaluate the doses of aluminum hydroxide (OH3 Al) received to achieve a better serum phosphate control. Thirty-seven patients were treated with continuous ambulatory peritoneal dialysis (CAPD) divided in 22 diabetics and 15 non-diabetics. Forty-nine patients were treated with hemodialysis… (More)

Topics

Cite this paper

@article{Maci1990DiabeticPO, title={Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.}, author={M Maci{\`a} and Francisco Coronel and Jessica Torrente and A. S{\'a}nchez and Fernando Tornero and Antonio Barrientos}, journal={Advances in peritoneal dialysis. Conference on Peritoneal Dialysis}, year={1990}, volume={6}, pages={50-2} }